Melissa Mastroianni, MD

Biotechnology; Breast; Industry; Microsurgery; Technology; Torso; Patient Outcome Assessment

• Wnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model.Mastroianni M, Kim S, Kim YC, Esch A, Wagner C, Alexander CM. Wnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model. Cancer Letters 2010, 289: 23-31. PMID: 19665836, PMCID: PMC2874254, DOI: 10.1016/j.canlet.2009.07.012.
• Lower extremity soft tissue defect reconstruction with the serratus anterior flap.Mastroianni M, Leto Barone AA, Shanmugarajah K, Leonard DA, Di Rosa L, Feingold RS, Israeli R, Cetrulo CL. Lower extremity soft tissue defect reconstruction with the serratus anterior flap. Microsurgery 2014, 34: 183-7. PMID: 24307318, DOI: 10.1002/micr.22191.
• Genetically modified porcine split-thickness skin grafts as an alternative to allograft for provision of temporary wound coverage: preliminary characterization.Leto Barone AA, Mastroianni M, Farkash EA, Mallard C, Albritton A, Torabi R, Leonard DA, Kurtz JM, Sachs DH, Cetrulo CL. Genetically modified porcine split-thickness skin grafts as an alternative to allograft for provision of temporary wound coverage: preliminary characterization. Burns : Journal Of The International Society For Burn Injuries 2015, 41: 565-74. PMID: 25406888, DOI: 10.1016/j.burns.2014.09.003.
• Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes.Gfrerer L, Mattos D, Mastroianni M, Weng QY, Ricci JA, Heath MP, Lin A, Specht MC, Haynes AB, Austen WG, Liao EC. Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes. Plastic And Reconstructive Surgery 2015, 135: 245e-252e. PMID: 25626807, DOI: 10.1097/PRS.0000000000000912.
• Nipple Loss following Nipple-Sparing Mastectomy.Mastroianni M, Lin AM, Smith BL, Austen WG, Colwell AS. Nipple Loss following Nipple-Sparing Mastectomy. Plastic And Reconstructive Surgery 2016, 138: 24e-30e. PMID: 27348682, DOI: 10.1097/PRS.0000000000002296.
• Skin grafts from genetically modified α-1,3-galactosyltransferase knockout miniature swine: A functional equivalent to allografts.Leonard DA, Mallard C, Albritton A, Torabi R, Mastroianni M, Sachs DH, Kurtz JM, Cetrulo CL. Skin grafts from genetically modified α-1,3-galactosyltransferase knockout miniature swine: A functional equivalent to allografts. Burns : Journal Of The International Society For Burn Injuries 2017, 43: 1717-1724. PMID: 28602591, PMCID: PMC5722691, DOI: 10.1016/j.burns.2017.04.026.
• Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival.Mastroianni M, Ng ZY, Goyal R, Mallard C, Farkash EA, Leonard DA, Albritton A, Shanmugarajah K, Kurtz JM, Sachs DH, Macri LK, Kohn J, Cetrulo CL. Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival. Journal Of Burn Care & Research : Official Publication Of The American Burn Association 2018, 39: 363-373. PMID: 28639977, PMCID: PMC5720930, DOI: 10.1097/BCR.0000000000000597.
• Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions.Mastroianni M, Lin A, Hughes K, Colwell AS. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions. Plastic And Reconstructive Surgery 2019, 143: 271e-275e. PMID: 30489497, DOI: 10.1097/PRS.0000000000005192.
• Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.Gama AR, Ng ZY, Shanmugarajah K, Mastroianni M, Randolph MA, Lellouch AG, Kohn J, Cetrulo CL. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model. Journal Of Burn Care & Research : Official Publication Of The American Burn Association 2020, 41: 1172-1178. PMID: 32352521, DOI: 10.1093/jbcr/iraa062.
• Cutaneous leukocyte lineages in tolerant large animal and immunosuppressed clinical vascularized composite allograft recipients.Leonard DA, Powell HR, Defazio MW, Shanmugarajah K, Mastroianni M, Rosales IA, Farkash EA, Colvin RB, Randolph MA, Sachs DH, Kurtz JM, Cetrulo CL. Cutaneous leukocyte lineages in tolerant large animal and immunosuppressed clinical vascularized composite allograft recipients. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2021, 21: 582-592. PMID: 32741100, PMCID: PMC7854956, DOI: 10.1111/ajt.16230.